EN Mobile Logo

Search form


ENDO 2017

ENDO 2017

The Endocrine Society's annual meeting, ENDO 2017, will take place April 1-4 in Orlando, FL.

ENDO 2017

Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.

Could corticosteroid use put your patients at a greater risk of metabolic syndrome?

Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.

Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.

Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.

Research presented at ENDO 2017 explored options to reduce complications in patients with diabetes and microalbuminuria and patients with cystic fibrosis.

Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.


Subscribe to ENDO 2017 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.